Herculite Products, Inc. Completes Capacity Expansion

Herculite Products Inc., a leading innovator and manufacturer of high-performance and custom fabrics is pleased to announce it has completed the second phase of a multiyear strategic investment into its facilities adding significant additional capacity.

Herculite’s multiyear, multimillion-dollar investment is focused on strengthening their position as a global leader in high-performance reinforced textile composites by increasing production capabilities, expanding manufacturing capacity, and improving organizational efficiency.

The recently completed phase was specifically focused on increasing manufacturing capacity at its Emigsville, Pennsylvania facility. This additional capacity has allowed Herculite to further grow its U.S.-based workforce, achieve record fabric production levels and respond to the historical and unprecedented demand across all Herculite product lines.

The next phases of Herculite’s strategic investment will continue to build on our long history of operational excellence. This strategic investment will significantly advance our organization in its mission to help our customers grow their business by delivering products and services of exceptional value distinguished by their quality and innovation on time.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version